Neolleoen pharmaceutical INC is focusing on biopharmaceutical research, and commits to R& D, manufacturing and marketing of a variety of biopharmaceuticals and pet drugs. In the field of pet, we have innovatively applied molecular modification technology, drug transformation technology, drug controlled release, sustained-release targeted drug delivery technology, drug transdermal and mucosal precise drug delivery technology in product formulation and production process, which grants the products unique curative effects for the prevention, treatment and control of dog and cat diseases.

The cornerstone of our business is innovation based on scientific research. We have a strong and scientific-proven product that is one of the most innovative in the pet industry. Our agency companies are located in more than 20 countries / regions in America, Europe and Asia. We have successfully marketed our products in more than 60 countries / regions, and have a network of joint manufacturing bases and R & D facilities around the world.

By consistently providing high-quality, professional products and services, the health and longevity of pets can be guaranteed and prolonged, allowing pets and people to enjoy more time together. Our goal is to become the preferred partners of veterinarians and pet owners, contributing to the continuous success of customers.

       美国 NEOLLEOEN  制药公司是一家专注以生物制药研究为驱动力的公司，致力于研发、制造和销售各种生物药品及宠物药品。在宠物领域我们创新地将分子修饰技术，药物转晶型技术，药物控释、缓释靶向给药技术，药物透皮、粘膜精准给药技术应用于产品配方及生产工艺中，使得我们在用于预防、治疗和控制犬、猫科动物疾病的产品获得独特的疗效。

      我们业务的基石始终是基于科学研究的创新，拥有强大的，经过科学验证的宠物业界最具创新性的产品组合之一，我们在美洲、欧洲、亚洲20多个国家/地区设有办事处，我们在60多个国家/地区成功营销我们的产品，并在全球范围内拥有联合制造基地和研发设施网络。

      通过始终如一地提供高质量，专业性的产品和服务使宠物和人们能够一起享受时间，以确保宠物的健康和长寿，我们的目标是成为兽医、宠物所有者的首选合作伙伴，并为客户的持续成功做出贡献。